Lumexa Imaging Holdings, Inc. (LMRI)
| Market Cap | 1.12B |
| Revenue (ttm) | 1.03B +10.1% |
| Net Income | -37.70M |
| EPS | -0.49 |
| Shares Out | 96.08M |
| PE Ratio | n/a |
| Forward PE | 15.59 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 699,893 |
| Open | 11.78 |
| Previous Close | 11.74 |
| Day's Range | 11.36 - 12.06 |
| 52-Week Range | 6.45 - 19.45 |
| Beta | n/a |
| Analysts | Strong Buy |
| Price Target | 17.29 (+48.54%) |
| Earnings Date | Aug 12, 2026 |
About LMRI
Lumexa Imaging Holdings, Inc. owns and operates diagnostic imaging centres in the United States. The company provides outpatient medical imaging services, such as magnetic resonance imaging (MRI), computed tomography (CT), and positron emission tomography (PET) services, as well as X-ray, ultrasound, and mammography diagnostic and screening imaging services. Lumexa Imaging Holdings, Inc. was founded in 2018 and is based in Raleigh, North Carolina.
Financial Performance
In 2025, Lumexa Imaging Holdings's revenue was $1.02 billion, an increase of 7.82% compared to the previous year's $948.87 million. Losses were -$47.10 million, -49.94% less than in 2024.
Financial StatementsAnalyst Summary
According to 8 analysts, the average rating for LMRI stock is "Strong Buy." The 12-month stock price target is $17.29, which is an increase of 48.54% from the latest price.
News
Lumexa Imaging Announces Second Quarter 2026 Earnings Conference Call Date
RALEIGH, N.C., July 29, 2026 (GLOBE NEWSWIRE) -- Lumexa Imaging (Nasdaq: LMRI), one of the nation's largest providers of outpatient imaging services, today announced it will release its second quarter...
Lumexa Imaging forms strategic joint venture with Hospital for Special Surgery
Lumexa Imaging (LMRI) announced the formation of a strategic joint venture with Hospital for Special Surgery. The collaboration represents Lumexa Imaging’s ninth joint venture. Lumexa Imaging and HSS ...
Lumexa Imaging Announces Joint Venture with Hospital for Special Surgery (HSS) to Expand Advanced Outpatient Imaging in New York
RALEIGH, N.C., June 02, 2026 (GLOBE NEWSWIRE) -- Lumexa Imaging (NASDAQ: LMRI), one of the nation's largest providers of outpatient imaging services, today announced the formation of a strategic joint...
Lumexa Imaging price target lowered to $9 from $15 at Barclays
Barclays lowered the firm’s price target on Lumexa Imaging (LMRI) to $9 from $15 and keeps an Overweight rating on the shares. The firm says RadNet is outperforming Lumexa on…
Lumexa Imaging director buys 30K shares of common stock
In a regulatory filing, Lumexa Imaging (LMRI) disclosed that its director, Henry Cooper, bought 30K shares of common stock on May 14th in a total transaction size of $223K. Shares…
Lumexa Imaging Holdings Earnings Call Transcript: Q1 2026
Q1 revenue grew 3% year-over-year to $253 million, with advanced modalities driving 7% volume growth and PET up 23%. Adjusted EBITDA was flat at $51.2 million, impacted by weather and seasonality, but guidance for 2026 remains strong with expected ramp in the second half.
Lumexa Imaging Holdings Earnings release: Q1 2026
Lumexa Imaging Holdings released its Q1 2026 earnings on May 12, 2026, summarizing the period's financial results.
Lumexa Imaging Holdings Quarterly report: Q1 2026
Lumexa Imaging Holdings has published its Q1 2026 quarterly earnings report on May 12, 2026.
Lumexa Imaging Announces First Quarter 2026 Results
RALEIGH, N.C., May 12, 2026 (GLOBE NEWSWIRE) -- Lumexa Imaging (Nasdaq: LMRI), one of the nation's largest providers of outpatient imaging services, today announced results for the first quarter ended...
Lumexa Imaging Advances Growth Strategy by Adding Four New Imaging Centers
RALEIGH, N.C., May 12, 2026 (GLOBE NEWSWIRE) -- Lumexa Imaging (NASDAQ: LMRI), one of the nation's largest providers of outpatient imaging services, today announced the addition of four new locations ...
Lumexa Imaging Announces First Quarter 2026 Earnings Conference Call Date
RALEIGH, N.C., April 28, 2026 (GLOBE NEWSWIRE) -- Lumexa Imaging (NASDAQ: LMRI), one of the nation's largest providers of outpatient imaging services, today announced it will release its first quarter...
Lumexa Imaging Holdings Proxy statement: Proxy filing
Lumexa Imaging Holdings filed a proxy statement on April 28, 2026, providing details for shareholder voting and corporate governance matters.
Lumexa Imaging Holdings Proxy statement: Proxy filing
Lumexa Imaging Holdings filed a proxy statement on April 28, 2026, providing details for shareholder voting and corporate governance matters.
Lumexa Imaging appoints Lynch as Chief Growth Officer
Lumexa Imaging (LMRI) announced the appointment of Kyle Lynch as its new Chief Growth Officer, CGO. Lynch joins the executive leadership team to lead the company’s enterprise growth strategy, with…
Lumexa Imaging Appoints Kyle Lynch as Chief Growth Officer
Proven healthcare growth leader to drive disciplined, profitable expansion and scale across Lumexa Imaging's platform Proven healthcare growth leader to drive disciplined, profitable expansion and sca...
Lumexa Imaging price target lowered to $15 from $23 at Barclays
Barclays lowered the firm’s price target on Lumexa Imaging (LMRI) to $15 from $23 and keeps an Overweight rating on the shares after meeting with management. The company reiterated its…
Lumexa Imaging price target lowered to $17 from $23 at Raymond James
Raymond James lowered the firm’s price target on Lumexa Imaging (LMRI) to $17 from $23 and keeps a Strong Buy rating on the shares following Q4 earnings. The firm notes…
Lumexa Imaging Holdings, Inc. Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses
SAN DIEGO, March 26, 2026 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP is investigating potential claims on behalf of investors of Lumexa Imaging Holdings, Inc. (NASDAQ: LMRI). The investigation focuses o...
Lumexa Imaging Holdings Inc trading resumes
09:39 EDT Lumexa Imaging (LMRI) Holdings Inc trading resumes
Lumexa Imaging Holdings Inc trading halted, volatility trading pause
09:34 EDT Lumexa Imaging (LMRI) Holdings Inc trading halted, volatility trading pause
Lumexa Imaging Holdings Earnings Call Transcript: Q4 2025
Q4 and full-year 2025 saw strong revenue and Adjusted EBITDA growth, driven by advanced imaging, new center openings, and operational efficiencies. 2026 guidance projects continued growth, with advanced modalities outpacing routine, and a focus on margin expansion and capital discipline.
Lumexa Imaging Holdings Annual report: Q4 2025
Lumexa Imaging Holdings has published its Q4 2025 annual report on March 26, 2026.
Lumexa Imaging Holdings Earnings release: Q4 2025
Lumexa Imaging Holdings released its Q4 2025 earnings on March 26, 2026, summarizing the period's financial results.
Lumexa Imaging Holdings Slides: Investor presentation
Lumexa Imaging Holdings has posted slides in relation to its latest quarterly earnings report, which was published on March 26, 2026.
Lumexa Imaging Announces Fourth Quarter and Full Year 2025 Results, Reiterates Full Year 2026 Guidance
RALEIGH, N.C., March 26, 2026 (GLOBE NEWSWIRE) -- Lumexa Imaging (Nasdaq: LMRI), one of the nation's largest providers of outpatient imaging services, today announced certain financial results for the...